Cargando…
RNA therapeutics – The potential treatment for myocardial infarction
RNA therapeutics mainly control gene expression at the transcript level. In contrast to conventional gene therapy which solely increases production of a protein, delivered RNAs can enhance, reduce or abolish synthesis of a particular protein, which control its relevant activities in a more diverse f...
Autores principales: | Chu, Hunghao, Kohane, Daniel S., Langer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581817/ https://www.ncbi.nlm.nih.gov/pubmed/31245491 http://dx.doi.org/10.1016/j.reth.2016.03.002 |
Ejemplares similares
-
Targeting necroptosis as therapeutic potential in chronic myocardial infarction
por: Piamsiri, Chanon, et al.
Publicado: (2021) -
New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction
por: Zhang, Zenglei, et al.
Publicado: (2021) -
Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target
por: Ghobrial, Mina, et al.
Publicado: (2023) -
Modified mRNA as a Treatment for Myocardial Infarction
por: Wang, Yu, et al.
Publicado: (2023) -
Therapeutic Use of Stem Cells for Myocardial Infarction
por: Madigan, Mariah, et al.
Publicado: (2018)